Home/Filings/4/0001144204-19-027766
4//SEC Filing

Howell Stephen B. 4

Accession 0001144204-19-027766

CIK 0000318306other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 5:10 PM ET

Size

31.1 KB

Accession

0001144204-19-027766

Insider Transaction Report

Form 4
Period: 2009-05-27
Transactions
  • Award

    Common stock

    2012-01-23+300495 total
  • Award

    Stock Option (right to buy)

    2009-05-27+500500 total
    Exercise: $69.00Exp: 2019-05-27Common stock (500 underlying)
  • Award

    Stock Option (right to buy)

    2010-05-26+600600 total
    Exercise: $122.50Exp: 2020-05-26Common stock (600 underlying)
  • Award

    Common stock

    2015-05-11+75,00075,495 total
  • Award

    Stock Option (right to buy)

    2009-05-27+200200 total
    Exercise: $69.00Exp: 2019-05-27Common stock (200 underlying)
  • Award

    Stock Option (right to buy)

    2015-05-11+75,00075,000 total
    Exercise: $7.34Exp: 2025-05-11Common stock (75,000 underlying)
  • Award

    Stock Option (right to buy)

    2016-12-13+50,00050,000 total
    Exercise: $4.45Exp: 2026-12-13Common stock (50,000 underlying)
  • Award

    Stock Option (right to buy)

    2011-05-26+700700 total
    Exercise: $113.50Exp: 2021-05-26Common stock (700 underlying)
  • Award

    Stock Option (right to buy)

    2012-05-24+700700 total
    Exercise: $30.50Exp: 2022-05-24Common stock (700 underlying)
  • Award

    Stock Option (right to buy)

    2012-12-11+2,0002,000 total
    Exercise: $11.50Exp: 2022-12-11Common stock (2,000 underlying)
  • Award

    Stock Option (right to buy)

    2014-03-07+10,00010,000 total
    Exercise: $18.50Exp: 2024-03-07Common stock (10,000 underlying)
  • Award

    Stock Option (right to buy)

    2016-02-11+50,00050,000 total
    Exercise: $2.31Exp: 2026-02-11Common stock (50,000 underlying)
  • Award

    Stock Option (right to buy)

    2017-12-14+30,00030,000 total
    Exercise: $16.00Exp: 2027-12-14Common stock (30,000 underlying)
Footnotes (2)
  • [F1]The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014.
  • [F2]Vests 100% six months after grant date.

Issuer

ABEONA THERAPEUTICS INC.

CIK 0000318306

Entity typeother

Related Parties

1
  • filerCIK 0001464306

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:10 PM ET
Size
31.1 KB